Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Randomized, Phase 3, Double Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High risk, Locally Advanced Cervical Cancer (KEYNOTE A18 / ENGOT cx11)
NCT Number:
NCT04221945
Phase:
III
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Cervix Uteri
Study Objectives:
The purpose of this study is to evaluate the efficacy and safety of pembrolizumab plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer.
Study Documents
(MUSC NetID required for document access)